Dr. Dröge invited to speak at two World Congresses on Cancer

In view of his excellent contributions to the field of cancer, Dr. Wulf Dröge, world-renowned research scientist and Senior Vice-President, Research and Development at Immunotec, has accepted a prestigious invitation to speak at the BIT’s 3rd World Cancer Congress (WCC) in Singapore being held from June 22 to 25, 2010 and at the Second World Congress on Cancer (WCC) in Kerala, India being held from September 3 to 5, 2010.

BIT’s 3rd World Cancer Congress (WCC) – Singapore
BIT Life Sciences is dedicated to creating a global intelligent exchange channel to address professional needs for sharing information and inspiring your scientists’ career growth. At the BIT’s 3rd World Cancer Congress (WCC), Dr. Dröge will present the results of Immunotec’s clinical lung cancer trial.

Second World Congress on Cancer (WCC) – Kerala India
This symposium will bring together a panel of highly-accomplished experts in various aspects of cancer and will be attended by hundreds of doctors and researchers from Modern Medicine, Homeopathy, Naturopathy, Chinese Medicine etc. Modern and traditional practitioners of medicine from all over the world will be invited. Presentations will encompass basic studies and clinical trials, and topics will also address other key related issues.

Immunotec congratulates Dr. Dröge on his invitation to speak at these important conferences.